Holen Sie sich die Stockscreener-App
4.65
6.95%
-0.3473
Handel nachbörslich:
5.25
0.60
+12.90%
Schlusskurs vom Vortag:
$4.9973
Offen:
$4.94
24-Stunden-Volumen:
24,839
Relative Volume:
0.84
Marktkapitalisierung:
$16.98M
Einnahmen:
$11.68M
Nettoeinkommen (Verlust:
$-8.85M
KGV:
-1.9295
EPS:
-2.41
Netto-Cashflow:
$-14.61M
1W Leistung:
-12.43%
1M Leistung:
-26.31%
6M Leistung:
-37.92%
1J Leistung:
+93.75%
1-Tages-Spanne:
$4.65
$4.9986
1-Wochen-Bereich:
$4.65
$5.44
52-Wochen-Spanne:
$1.78
$10.40
Pulmatrix Inc Stock (PULM) Company Profile
Firmenname
Pulmatrix Inc
Sektor
Branche
Telefon
(888) 355-4440
Adresse
945 CONCORD STREET, FRAMINGHAM, MA
Vergleichen Sie PULM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
4.65 | 18.26M | 11.68M | -8.85M | -14.61M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-02-09 | Eingeleitet | H.C. Wainwright | Buy |
Pulmatrix Inc Aktie (PULM) Neueste Nachrichten
Has Pulmatrix Inc. found a price floorStop Loss & Free AI Powered Buy and Sell Recommendations - Newser
Buy Signal for Pulmatrix Inc. Stock Key Technical Indicators to WatchDollar Strength & AI Based Buy and Sell Signals - Newser
What analysts say about Pulmatrix Inc. stock outlookJuly 2025 Levels & Community Trade Idea Sharing Platform - Newser
What high frequency data says about Pulmatrix Inc. [2025 Market Trends]Free Verified Technical Trade Signals - Newser
Applying sector rotation models to Pulmatrix Inc.Risk Aware Trading Ideas with Alert Levels - Newser
Pulmatrix Inc. stock retracement – recovery analysisSwing Trade Entry and Exit Point Analysis - Newser
How high can Pulmatrix Inc. stock price go in 2025Insider Buying & Daily Entry Point Trade Alerts - Newser
Pulmatrix Inc. Ranks High in Smart Money TrackerWatchlist for Smart Swing Trading Updated - 선데이타임즈
Tools to assess Pulmatrix Inc.’s risk profileAlgorithmic Prediction of Market Breakouts - Newser
Measuring Pulmatrix Inc.’s beta against major indicesFree Reliable Investment Entry Point Signals - Newser
How Pulmatrix Inc. stock performs during market volatilityWatchlist Generator With Real-Time Entry - Newser
Using Ichimoku Cloud for Pulmatrix Inc. technicalsRisk Managed Watchlist with Breakout Picks - Newser
Tick level data insight on Pulmatrix Inc. volatilityFree Day Trading Signals With High Precision - Newser
Building trade automation scripts for Pulmatrix Inc.Market Ready Picks with Technical Support - Newser
What Fibonacci levels say about Pulmatrix Inc. reboundDay Trading Plan with Entry Risk Management - Newser
Price action breakdown for Pulmatrix Inc.Scalable Strategy with Chart Confirmation - Newser
Pulmatrix Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingAI Screener Based Stock Summary Report - Newser
Detecting price anomalies in Pulmatrix Inc. with AIReal Time Trade Execution Alert Plan - Newser
Pulmatrix Inc. stock momentum explainedFree Trend Following Strategy With Stop Loss - Newser
When is the best time to exit Pulmatrix Inc.Real-Time Investment Picks with Accuracy - Newser
Is Pulmatrix Inc. showing signs of accumulationReal-Time Entry Forecast with Accuracy Metrics - Newser
Why Pulmatrix Inc. stock attracts strong analyst attentionReal Time Alert System for Market Moves - Newser
Short Interest in Pulmatrix, Inc. (NASDAQ:PULM) Expands By 51.2% - Defense World
Pulmatrix 2024 Q4 Earnings Narrowed Losses and Record Net Income - AInvest
Pulmatrix (PULM) Q2 Revenue Falls 100% - The Globe and Mail
Pulmatrix Reports Q2 2025 Financial Results, Plans Inhalation Asset Divestment Ahead of Cullgen Merger - AInvest
Pulmatrix to divest iSPERSE patent portfolio amid merger with Cullgen. - AInvest
Pulmatrix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Pulmatrix to potentially divest its patent portfolio for iSPERSE technology - TipRanks
Pulmatrix, Inc. SEC 10-Q Report - TradingView
Pulmatrix Announces Second Quarter 2025 Financial Results and Di - GuruFocus
Pulmatrix Q2 2025: Proposed merger to close in 2025, divesting iSPERSE technology. - AInvest
Pulmatrix Q2 revenue falls to zero, net loss widens - MarketScreener
Pulmatrix Announces Q2 2025 Results, Proposes Inhalation Assets Divestment. - AInvest
Pulmatrix to Divest 146-Patent Inhalation Technology Portfolio as Cullgen Merger Advances - Stock Titan
Finanzdaten der Pulmatrix Inc-Aktie (PULM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):